Polar Asset Management Partners Inc. Janux Therapeutics, Inc. Transaction History
Polar Asset Management Partners Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 13,500 shares of JANX stock, worth $689,850. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,500Holding current value
$689,850% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding JANX
# of Institutions
162Shares Held
37.5MCall Options Held
85.3KPut Options Held
644K-
Ra Capital Management, L.P. Boston, MA9.17MShares$468 Million5.81% of portfolio
-
Janus Henderson Group PLC London, X02.52MShares$129 Million0.06% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.4MShares$123 Million3.93% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$120 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.08MShares$106 Million0.17% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $2.13B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...